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The actinobacterial cholesterol catabolic gene cluster contains a subset of genes that encode -oxidation
enzymes with a putative role in sterol side chain degradation. We investigated the physiological roles of several
genes, i.e., fadD17, fadD19, fadE26, fadE27, and ro04690DSM43269, by gene inactivation studies in mutant strain
RG32 of Rhodococcus rhodochrous DSM43269. Mutant strain RG32 is devoid of 3-ketosteroid 9-hydroxylase
(KSH) activity and was constructed following the identiﬁcation, cloning, and sequential inactivation of ﬁve
kshA gene homologs in strain DSM43269. We show that mutant strain RG32 is fully blocked in steroid ring
degradation but capable of selective sterol side chain degradation. Except for RG32fadD19, none of the
mutants constructed in RG32 revealed an aberrant phenotype on sterol side chain degradation compared to
parent strain RG32. Deletion of fadD19 in strain RG32 completely blocked side chain degradation of C-24
branched sterols but interestingly not that of cholesterol. The additional inactivation of fadD17 in mutant
RG32fadD19 also did not affect cholesterol side chain degradation. Heterologously expressed
FadD19DSM43269 nevertheless was active toward steroid-C26-oic acid substrates. Our data identiﬁed FadD19 as
a steroid-coenzyme A (CoA) ligase with an essential in vivo role in the degradation of the side chains of C-24
branched-chain sterols. This paper reports the identiﬁcation and characterization of a CoA ligase with an in
vivo role in sterol side chain degradation. The high similarity (67%) between the FadD19DSM43269 and
FadD19H37Rv enzymes further suggests that FadD19H37Rv has an in vivo role in sterol metabolism of Myco-
bacterium tuberculosis H37Rv.
Phytosterols are among the most abundant sterols in nature
and are mineralized from decaying plant material by soil bac-
teria, e.g., Rhodococcus strains belonging to the class Actino-
bacteria (37). Microbial degradation of sterol molecules in-
volves elimination of the alkyl side chain and opening of the
polycyclic steroid nucleus (Fig. 1) (1, 13, 26–28). The order of
these two processes varies between bacterial genera and even
between members of the same genus (23).
Prior to their degradation, sterols are actively transported
into the actinobacterial cells by the Mce4 steroid transporter
(17, 20, 36). Following uptake by Rhodococcus jostii RHA1
cells, the cytochrome P450 monooxygenase CYP125 initiates
degradation of the sterol side chain by catalyzing hydroxylation
of the C-26 or C-27 carbon (Fig. 1A and B, reaction 1) (5, 15,
19, 23). After complete oxidation of the hydroxylated terminal
carbon atom to its carboxylic acid intermediate (Fig. 1, com-
pounds III and XI), the sterol side chain is shortened by a
process similar to -oxidation of fatty acids. This process is
initiated by an ATP-dependent sterol/steroid-coenzyme A
(CoA) ligase (Fig. 1A and B, reaction 3) (6, 27, 28) catalyzing
the CoA activation of the C26 carboxylic acid intermediates
(Fig. 1, compounds III and XI). An ATP-dependent steroid-
CoA ligase (65 kDa) from Mycobacterium sp. strain NRRL
B3805 was puriﬁed to near homogeneity and shown to be
highly speciﬁc toward C26 carboxylic sterols (6). The gene
encoding this activity remained unknown, however. Thiolytic
cleavage results in shortening of the cholesterol side chain in
several rounds of -oxidation via C24 (Fig. 1A, compound IV)
and C22 (Fig. 1A, compounds V and VII) intermediates and
concomitant release of propionyl-CoA and acetyl-CoA, re-
spectively. This process has been elucidated at the biochemical
level in strains of Mycobacterium and Nocardia and proceeds
differently for -sitosterol than for cholesterol (Fig. 1) (9, 10,
13, 14, 27–29).
Knowledge of genes involved in microbial degradation of the
alkyl sterol side chain is extremely limited. Recently, a wealth
of information on sterol catabolism was provided by the iden-
tiﬁcation of a cholesterol catabolic gene cluster in R. jostii
RHA1, encoding several enzymes with predicted functions in
-oxidation (36). A subset of these genes (i.e., ro04683 to
ro04694) is located proximal to cyp125, encoding a steroid
26-hydroxylase involved in sterol side chain degradation (5, 15,
19, 23, 36). The aim of our work is to decipher the roles of
these genes in sterol metabolism, particularly those genes en-
coding steps of the -oxidation cycle of sterol side chain deg-
radation. The strain RHA1 cholesterol transcriptome was used
to identify two candidate genes, i.e., fadD17 (ro04691) and
fadD19 (ro04689), encoding putative acyl-CoA ligases, which
were highly upregulated during growth on cholesterol (Fig.
2A) (36). Previous studies on FadD17 and FadD19 homologs
from Mycobacterium tuberculosis H37Rv showed that in vitro
they act as CoA ligases capable of activation of long-chain fatty
acids (31). Their in vivo physiological roles remained unknown.
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4455Only a few examples of sterol side chain degradation genes
have been reported, including baiB of Eubacterium sp. strain
VPI 12708 and caiA of Pseudomonas sp. strain Chol1, encoding
a CoA ligase and an acyl-CoA dehydrogenase, respectively,
involved in cholic acid degradation (4, 12). Also, fadA5 of M.
tuberculosis H3Rv was shown to encode a thiolase with a role
in cholesterol side chain degradation (18).
Molecular characterization studies on sterol side chain deg-
radation are generally hampered by the lack of a stable,
genetically accessible strain with inactivated steroid ring
degradation but capable of selective sterol side chain degra-
dation. Interestingly, Rhodococcus rhodochrous IFO3338
(DSM43269) is amenable to genetic manipulation and able
to selectively degrade the sterol side chain in the presence of
iron chelators, which inhibit 3-ketosteroid 9-hydroxylase
(KSH) activity (2, 23). KSH is a two-component enzyme sys-
tem, consisting of a terminal oxygenase, KshA, and a ferredox-
in-reductase, KshB, and a key enzymatic step in steroid ring
opening during microbial steroid catabolism (22, 33, 35). We
created a genetically stable, multiple kshA gene deletion null
FIG. 1. Schematic overview of the side chain degradation pathways of cholesterol (A), -sitosterol and campesterol (B), and steroid ring
opening (C) in actinobacteria (6, 10, 36). The arrow numbering indicates reaction steps which are explained in the text. Abbreviations: CoA,
coenzyme A; CHO, cholesterol oxidase; 3-HSD, 3-hydroxysteroid dehydrogenase; KSTD, 3-ketosteroid 1-dehydrogenase; KSH, 3-ketosteroid
9-hydroxylase.
FIG. 2. (A) -Oxidation gene cluster comprised of ro04677 to ro04695 within the cholesterol catabolic gene cluster of R. jostii RHA1 (16, 36).
The relative fold change of expression previously observed during growth on cholesterol compared to pyruvate is also shown (36). (B and C)
Genetic organization of homologs of ro04688 to ro04690 and ro04691 to ro04695 of R. rhodochrous DSM43269, respectively.
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lacking KSH activity. Analogously to the chemical inhibition of
strain DSM43269 by iron chelators, mutant strain RG32 was
completely blocked in steroid ring degradation and capable of
selective sterol side chain degradation, thereby accumulating
3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid (1,4-BNC) and
1,4-androstadiene-3,17-dione (ADD) (Fig. 1, compounds V
and VI) from sterols. The strain RG32 was used as a tool to
assess the role of various genes in sterol side chain degrada-
tion. We identiﬁed fadD19 as an essential gene for the degra-
dation of the C-24 branched-chain sterols campesterol and
-sitosterol but not cholesterol. Direct enzyme activity mea-
surement of heterologously produced FadD19 of DSM43269
conclusively identiﬁed its function as a steroid-CoA ligase in
view of its ability to activate steroid carboxylic acid side chains.
MATERIALS AND METHODS
Bacterial strains, growth conditions, plasmids, and chemicals. Bacterial
strains and plasmids used in this study are listed in Table 1. Escherichia coli
strains and R. rhodochrous DSM43269 were grown in Luria-Bertani (Sigma,
Zwijndrecht, Netherlands) medium at 37°C and 30°C, respectively. Liquid cul-
tures were grown with shaking (220 rpm). Ampicillin (100 gm l
1), kanamycin
(25 gm l
1), or apramycin (50 gm l
1) was added to the medium if appro-
priate after autoclaving. For growth on solid medium, Difco agar (Becton, Le
Pont de Claix, France) was added at a ﬁnal concentration of 1.5% (wt/vol).
Cholesterol, campesterol, and coenzyme A trilithium salt were obtained from
Sigma-Aldrich. -Sitosterol was obtained from Acros Organics. 5-Cholestene-
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Source or
reference(s)
Strains
E. coli
BL21(DE3) Host for expression of T7-based plasmids Novagen
DH5 General host for cloning purposes Bethesda Research
Laboratories
S17-1 Host strain for conjugal mobilization of pK18mobsacB-derived
mutagenic plasmids to Rhodococcus strains
DSMZ culture
collection
Rhodococcus rhodochrous
DSM43269 Wild-type strain; potent sterol degrader; identical to strain
IFO3338
DSMZ culture
collection
RG32 Mutant strain of DSM43269 capable of selective sterol side chain
degradation; carries 5-fold unmarked kshA gene deletion
This study
RG32ro04690DSM43269 Gene deletion mutant of ro04690DSM43269 in R. rhodochrous strain
RG32
This study
RG32ro04690DSM43269 fadE26 Double deletion mutant of ro04690DSM43269 and fadE26 in R.
rhodochrous strain RG32
This study
RG32ro04690DSM432690 fadE26 fadE27 Gene inactivation mutant of fadE27 in RG32ro04690DSM43269
fadE26
This study
RG32fadD19 Gene deletion mutant of fadD19 in R. rhodochrous strain RG32 This study
RG32 fadD17 Gene inactivation mutant of fadD17 in R. rhodochrous strain RG32 This study
RG32fadD19 fadD17 Gene inactivation mutant of fadD17 in RG32fadD19 This study
Plasmids
pK18mobsacB Conjugative plasmid for gene mutagenesis in Rhodococcus; aphII
sacB oriT (RP4) lacZ
25, 34
pBluescript(II)KS General E. coli cloning vector; bla lacZ Stratagene
pRESQ E. coli-Rhodococcus shuttle vector; aphII lacZ-ccdB rep (pMVS301) 35
pZeRO2.1 General cloning vector Invitrogen
pBs-Pkan pBluescript(II)KS containing aphII promoter region 32
pET15b T7 promoter-based expression plasmid; bla lacI Novagen
pET15bfadD19DSM43269 pET15b containing fadD19DSM43269 This study
pDELBox pK18mobsacB-derived mutagenic plasmid for deletion of ro04683
to ro04694 in RHA1
This study
pDELfadD19DSM43269 pK18mobsacB-derived mutagenic plasmid for deletion of
fadD19DSM43269 in RG32
This study
pDELfadE26DSM43269 pK18mobsacB-derived mutagenic plasmid for deletion of
fadE26DSM43269 in RG32
This study
pDELro04690DSM43269 pK18mobsacB-derived mutagenic plasmid for deletion of
ro04690DSM43269 in RG32
This study
pfadE27DSM43269 pK18mobsacB-derived mutagenic plasmid for disruption of
fadE27DSM43269 in RG32
This study
pfadD17DSM43269 pK18mobsacB-derived mutagenic plasmid for disruption of
fadD17DSM43269 in RG32
This study
pRESQ4690 Genomic library clone DSM43269 carrying ro04690DSM43269 This study
pRESQ4693 Genomic library clone DSM43269 carrying fadE26DSM43269 This study
pCOMPfadD19DSM43269 pRESQ-derived plasmid carrying fadD19DSM43269 behind the aphII
promoter for functional complementation of RG32fadD19
This study
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4-Androstene-3,17-dione (AD), 1,4-androstadiene-3,17-dione (ADD), 23,24-bis-
norchol-5-en-22-oic acid-3-ol, 3-oxo-23,24-bisnorchol-4-en-22-oic acid (4-
BNC), 4-cholestene-3-one, 1,4-cholestadiene-3-one, 5-cholenic acid-3-ol, and
3-oxo-4-cholestene-26-oic acid were obtained from Steraloids. ATP was pur-
chased at Duchefa, Haarlem, Netherlands.
General molecular techniques. Recombinant DNA techniques were per-
formed according to standard protocols (24). DNA-modifying enzymes (re-
striction enzyme ligases and DNA polymerases) were purchased from Roche
(Mannheim, Germany), New England BioLabs (Beverly, MA), or Fermentas
(St. Leon-Rot, Germany) and were used according to the manufacturer’s pro-
tocols. All PCR products were obtained using Pwo polymerase (Roche) using
standard conditions: 30 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min.
DNA fragments were puriﬁed from an agarose gel using a Sigma Genelute gel
extraction kit.
Gene cloning of four kshA homologs of R. rhodochrous strain DSM43269 and
construction of kshA null mutant R. rhodochrous strain RG32. We previously
reported the cloning, heterologous expression, and characterization of a kshA
homolog of R. rhodochrous DSM43269 (22), that was renamed kshA4 (see Re-
sults). Four additional kshA homologs of R. rhodochrous DSM43269 were
cloned, sequenced, and deleted in DSM43269 as follows. A genomic library of R.
rhodochrous DSM43269 (22) was introduced by electroporation into kshA mu-
tant Rhodococcus erythropolis RG2 (35) for functional complementation of
growth on AD, resulting in a clone carrying 5.4 kb of insert DNA harboring the
kshA2 homolog of strain DSM43269. A mutagenic plasmid for unmarked kshA2
gene deletion in strain DSM43269 was constructed as follows. A 2.3-kb BglII
DNA fragment containing kshA2 and its upstream region was ligated into
pZeRO (pKSH503). A 1.6-kb BglII/HindIII DNA fragment containing kshA2
and its downstream region was ligated into pZeRO (pKSH516). A 1.2-kb
BamHI/Asp718I fragment of pKSH516 was ligated into BamHI/Asp718I-di-
gested pKSH503, and a 2.5-kb HindIII/SpeI DNA fragment of the resulting
construct carrying the kshA2 deletion was ligated into HindIII/XbaI-digested
pK18mobsacB (25), producing pKSH518 used to construct the kshA2 mutant of
R. rhodochrous. Next, genomic DNA was isolated from the kshA2 mutant and
used as template for PCR with kshA degenerate primers KshAType-F and
KshAType-R (33). The obtained 0.3-kb amplicon was cloned and sequenced,
identifying the kshA1 homolog from strain DSM43269. Gene-speciﬁc primers for
kshA1 (KshA1Rho-F and -R, Table 2) were developed and used to isolate a
clone from the genomic library of R. rhodochrous DSM43269 carrying kshA1.A
mutagenic plasmid for unmarked kshA1 gene deletion was constructed as fol-
lows. A 1.6-kb EcoRI (blunt-ended by Klenow)/Asp718I DNA fragment con-
taining the 5 part of kshA1 and its upstream region and a 2.3-kb BglII (blunt-
ended by Klenow)/BamHI DNA fragment containing the 3 part of kshA1 and its
downstream region were ligated stepwise into pBluescript(II)KS. A 3.4-kb XbaI/
EcoRI DNA fragment of the resulting construct carrying the kshA1 deletion was
ligated into XbaI/EcoRI-digested pK18mobsacB and used to construct a kshA1
kshA2 double gene deletion mutant of the R. rhodochrous kshA2 mutant.
Genomic DNA was again isolated from the kshA1 kshA2 mutant and used as
template for PCR with kshA degenerate primers. PCR product was obtained
both with primer pair KshAType-F and KshAType-R and with primer pair
KshA2-F and KshA2-R (33), the latter pair resulting in a 0.6-kb amplicon
containing the kshA3 homolog of strain DSM43269. Speciﬁc kshA3 primers
(KshA3Rho-F and-R, Table 2) were developed and used to isolate a clone
(pKSH800) from the genomic library carrying kshA3. A mutagenic plasmid for
unmarked kshA3 gene deletion was constructed as follows. A 3.5-kb BamHI
fragment of pKSH800 was ligated into BamHI-digested pBluescript(II)KS,
which was subsequently digested with BglII and MluI, blunt ended by Klenow
treatment, and self ligated. Next, a 1.7-kb BamHI fragment was ligated into
BamHI digested pK18mobsacB, rendering the plasmid for kshA3 gene deletion
of the R. rhodochrous kshA1 kshA2 mutant strain.
A mutagenic plasmid for kshA4 gene deletion was constructed as follows. A
4.2-kb XbaI/HindIII DNA fragment harboring kshA4 was subcloned into XbaI/
HindIII-digested pZeRO. The resulting plasmid was digested by XhoI, treated
with Klenow fragment, and digested with XbaI to give a 4.5-kb fragment har-
boring pZeRO and the downstream ﬂanking region of kshA4. The upstream
region of kshA4 was subsequently ligated as a 1.9-kb fragment liberated following
digestion by XhoI, treatment with Klenow fragment, and digestion by XbaI.
Next, a 2.8-kb PstI/BamHI fragment was cloned into PstI/BamHI-digested
pK18mobsacB, resulting in pKSH631 used for kshA4 gene deletion to construct
kshA1 kshA2 kshA3 kshA4 mutant strain RG31. Genomic DNA was iso-
lated from mutant strain RG31 and used as template for PCR with kshA degen-
erate primers KshAType-F and KshAType-R (33), resulting in the kshA5 ho-
molog of DSM43269. Speciﬁc kshA5 primers (KshA5Rho-F and -R, Table 2)
were developed to isolate a clone from the genomic library carrying kshA5.A
1.5-kb Eco47III fragment carrying the downstream region of kshA5 was cloned
into EcoRV-digested pBluescript(II)KS and subsequently ligated as an EcoRI/
Asp718I fragment into EcoRI/Asp718I-digested pBluescript(II)KS carrying a
1.6-kb Asp718I (Klenow-treated) fragment harboring kshA5 and its upstream
region. A 1.05-kb BglII/XhoI fragment of the resulting construct was ligated into
BamHI/SalI-digested pK18mobsacB, resulting in pKSH912 used for kshA5 gene
deletion to construct kshA1 kshA2 kshA3 kshA4 kshA5 mutant strain R.
rhodochrous RG32. Genomic DNA was isolated from mutant strain RG32 and
used as template for PCR with kshA degenerate primers KshAType-F and
KshAType-R (33), which did not reveal the presence of additional kshA genes.
Screening of a R. rhodochrous DSM43269 genomic library for ro04690 and
fadE26 homologs. Degenerate ro04690
DEG primers (Table 2) were based on
conserved amino acid sequences HTGE(I/V)A(S/T)M (amino acids [aa] 193 to
200) and PLPMPLQ (aa 306 to 312) in Ro04690. Degenerate fadE26
DEG prim-
ers (Table 2) were based on conserved amino acid sequences V(I/V)NGQKMW
(aa 153 to 160) and FGGGTNE(V/I) (aa 369 to 376) in FadE26RHA1. A genomic
library of R. rhodochrous DSM43269 (22) was screened by PCR using the
ro04690
DEG and fadE26
DEG primers for clones containing the full-length
ro04690 and fadE26 genes, respectively.
Targeted disruption and unmarked gene deletions in Rhodococcus strains.
Disruption and unmarked gene deletion mutants of R. rhodochrous DSM43269
were constructed using the sacB counterselection system (34).
Mutagenic plasmids for targeted gene deletion were constructed by PCR
ampliﬁcation of up- and downstream regions of the target genes using the
primers listed in Table 2. The obtained amplicons were separately subcloned into
EcoRV-digested pBluescript(II)KS. The amplicons were then ligated together
using a native restriction site from pBluescript(II)KS (EcoRI or XbaI) and the
restriction site that was introduced by PCR, being either BglII or NdeI. The
genomic fragment was then isolated by digestion with either EcoRI or XbaI and
HindIII and cloned into pK18mobsacB.
A construct for deletion of fadD19DSM43269 in strain RG32 was made as
follows: pRESQ-4690 was digested with EcoO119I and PstI, giving a 3.0-kb
fragment, whose 5 overhang was ﬁlled in with Klenow fragment and 3 overhang
was removed by T4 DNA polymerase. Plasmid pK18mobsacB was digested with
BamHI and made blunt ended by Klenow ﬁll-in and used for ligation with the
blunt-ended 3.0-kb fragment, giving pK18fadD19. A 751-bp deletion was intro-
duced by digesting pK18fadD19 with NspV and BamHI, followed by 5 overhang
ﬁll-in using Klenow fragment and self-ligation, yielding mutagenic plasmid
pDELfadD19DSM43269.
Mutagenic plasmids for targeted gene disruptions were obtained by PCR
ampliﬁcation of internal fragments of the target genes, using the primers listed
in Table 2. The amplicons were subsequently ligated into SmaI-digested
pK18mobsacB.
Mutagenic plasmids were transferred to Escherichia coli S17-1 by transforma-
tion and subsequently mobilized to R. rhodochrous DSM43269 by conjugational
transfer as described previously (34). All mutants were veriﬁed by PCR using
speciﬁc primers (Table 2) to conﬁrm deletion or disruption of the target gene(s).
Functional complementation of RG32fadD19. The fadD19DSM43269 gene was
ampliﬁed by PCR using the PCR primers compfadD19-F and compfadD19-R
(Table 2). The obtained PCR product of 1,673 bp was digested with Acc65I and
ligated into EcoRV/Acc65I-digested pBs-Pkan, yielding plasmid pBs-Pkan-
fadD19DSM43269. The pBs-Pkan-fadD19DSM43269 plasmid was digested with
SpeI/Acc65I to obtain the 2.1-kb Pkan-fadD19DSM43269 cassette that was subse-
quently ligated into SpeI/Acc65I-digested pRESQ, resulting in plasmid
pCOMPfadD19DSM43269 that was used to transform electrocompetent cells of
RG32fadD19 as described previously (8).
Whole-cell biotransformation of R. rhodochrous RG32-derived mutants and
steroid analyses. Cell cultures of R. rhodochrous RG32 and derived mutant
strains were grown overnight in liquid LB medium at 30°C with shaking (220
rpm) until mid-exponential phase. Stock solutions of sterols were prepared by
dissolution in acetone at a concentration of 25 mM and added to cultures at a
ﬁnal concentration of 0.5 mM. After further incubation for 3 days under the
same conditions, samples were taken for high-pressure liquid chromatography
(HPLC) analysis.
To analyze sterol conversions, 1-ml culture samples were taken and centri-
fuged (1 min at 16,000 	 g) and 0.5 ml of supernatant was mixed with 2 ml
methanol and ﬁltered prior to analysis by HPLC. HPLC was performed on an
Alltima C18 column (250 by 4.6 mm; 35°C; Alltech, Deerﬁeld, IL) using a mobile
phase consisting of methanol-water-formic acid (80:19:1) at a ﬂow rate of 1 ml
min
1 with UV detection at 254 nm. Authentic 1,4-androstadiene-3,17-dione
and 3-oxo-23,24-chola-1,4-dien-22-oic acid, obtained by incubating authentic
3-oxo-23,24-bisnorchol-4-en-22-oic acid with puriﬁed 3-ketosteroid dehydroge-
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VOL. 77, 2011 FadD19 OF RHODOCOCCUS RHODOCHROUS DSM43269 4459nase enzyme (1-KSTD1) (11), were used as references to enable quantiﬁcation
of the conversion rates. Steroids were extracted from culture broth using 2
volumes of ethyl acetate. Samples were directly applied onto the same HPLC and
detection system as described above, except that the mobile phase consisted of
acetonitrile-tetrahydrofuran (75:25) and the ﬂow rate was set at 2 ml min
1.
Authentic -sitosterol (a mixture of -sitosterol and campesterol) was incubated
with cholesterol oxidase (Sigma) to obtain 4-sitostene-3-one and 4-campestene-
3-one and used as reference sample.
Production of CoA ligase FadD19DSM43269. The fadD19DSM43269 gene was
ampliﬁed by PCR from genomic DNA of R. rhodochrous DSM43269 using
primer pair fadD19exp-F and fadD19Exp-R (Table 2). After subcloning of the
amplicon in pBluescript(II)KS, the gene was cloned into pET15b using NdeI and
BamHI, yielding pET15bfadD19DSM43269, and introduced into competent E. coli
BL21(DE3) cells for expression. Overexpression of FadD19DSM43269 was ob-
tained by growing 50-ml cultures in LB medium, supplemented with 0.5 M
sorbitol, 100 mM ampicillin, and 0.1 mM IPTG (isopropyl--D-thiogalactopyra-
noside) for 24 h at 25°C with shaking (220 rpm). Cells were harvested by
centrifugation (4,600 	 g, 15 min, 4°C). Cell pellets were resuspended in 50 mM
Tris buffer, pH 8.0, and cells were disrupted by sonication (10 times for 30 s each
at 10 m with 30-s intervals) on ice. To obtain cell extracts, cell debris was
removed by centrifugation (40,000 	 g, 20 min, 4°C). Proteins were analyzed by
SDS-PAGE analysis as described previously (24) and quantiﬁed using the Brad-
ford method, using the Bio-Rad reagent and bovine serum albumin (BSA) as a
standard.
Enzymatic activity of FadD19DSM43269. The activity of FadD19DSM43269 on
various carboxylic acid sterols was analyzed by thin-layer chromatography (TLC).
Reaction mixtures consisted of 20 mM Tris, pH 8.0, 5 mM MgCl2, 0.5 mM
substrate, and 2 mM ATP and/or 1 mM CoA, where applicable, in a ﬁnal volume
of 10 l. Reactions were initiated by the addition of 1 l of cell extract (CFE)
containing FadD19DSM43269 (
4 g of total protein). Care was taken to use
freshly produced enzyme from the same production batch in all experiments.
CFE of E. coli BL21(DE3) carrying empty pET15b was used as a negative
control. After4ho fincubation at 30°C, total reaction volumes were directly
applied to F254 silica gel TLC plates (Merck, Darmstadt, Germany) and sepa-
rated using a mobile phase consisting of 1-butanol–acetic acid–water (80:25:40)
for 30 min. Spots were visualized using Cer reagent consisting of 1% (wt/vol)
Ce(SO4)2, 2.5% (wt/vol) H3[P(Mo3O10)4]  H2O, and 8% (vol/vol) concentrated
H2SO4 and developed by heating with a hot air gun.
Phylogenetic tree construction. Protein sequences of CoA ligases from R. jostii
RHA1 were aligned using ClustalW; MEGA4.1 was used for phylogenetic tree
construction (30). Amino acid sequences, annotated as acyl-CoA ligases or
acyl-CoA synthetases, were obtained from the RHA1 genome website (www
.rhodococcus.ca) and used for phylogenetic tree construction. Furthermore,
BaiB of Eubacterium sp. strain VPI 12708 (accession number P19409) was in-
cluded in the phylogenetic tree.
Nucleotide sequence accession numbers. DNA nucleotide sequencing was
performed by Agowa (Berlin, Germany). The R. rhodochrous DSM43269 se-
quence data have been submitted to the DDBJ/EMBL/GenBank databases un-
der accession numbers HM588719 (pRESQ4690), HM588720 (pRESQ4693),
HQ425873 (kshA1), HQ425874 (kshA2), HQ425875 (kshA3), HQ425876
(kshA4), and HQ425877 (kshA5).
RESULTS
Cloning and molecular characterization of a total of ﬁve
kshA homologs from Rhodococcus rhodochrous DSM43269. We
previously reported the cloning, heterologous expression, and
characterization of the kshA gene of R. rhodochrous
DSM43269 (22). In the current work, four additional kshA
gene homologs from DSM43269 were cloned and sequenced as
described in detail in Materials and Methods. Thus, a total of
ﬁve kshA genes were identiﬁed in R. rhodochrous DSM43269.
The gene homologs were designated kshA1 through kshA5
based on the similarities of the encoded KshA protein se-
quences to those of the three known kshA genes (kshA1 to
kshA3)o fR. erythropolis SQ1 (33, 35). The previously reported
KshA from DSM43269 (22) and the ﬁfth KshA were less sim-
ilar in amino acid sequence to KshA1, KshA2, or KshA3 of
strain SQ1 than were the other newly identiﬁed KshA ho-
mologs of strain DSM43269 and were therefore renamed
KshA4 and KshA5, respectively.
Bioinformatic analysis revealed that the typical Rieske Fe2S2
binding domain (C-X-H-X16,17-C-X2-H) and the nonheme
Fe
2 motif (D-X3-D-X2-H-X4-H) (35) were present in all ﬁve
KshA homologs.
Construction and characterization of kshA null mutant
strain R. rhodochrous RG32 performing selective sterol side
chain degradation. The cloned DNA fragments of wild-type R.
rhodochrous DSM43269 were used to construct a 5-fold kshA
null mutant, designated strain RG32 (see Materials and Meth-
ods). Whole-cell biotransformations of 4-androstene-3,17-di-
one (AD, Fig. 1, compound VIII) by strain RG32 resulted in
69% molar conversion into 1,4-androstadiene-3,17-dione
(ADD, Fig. 1, compound VI) (Table 3 and Fig. 1C, KSTD
activity), which was not accumulated in detectable amounts by
wild-type strain DSM43269 (data not shown), conﬁrming im-
paired KSH activity (35). Next, mutant strain RG32 was tested
in whole-cell biotransformations for its ability to perform se-
lective side chain degradation on a range of sterols/steroids.
All compounds tested were converted into ADD (Fig. 1, com-
pound VI) and 3-oxo-23,24-bisnorchola-1,4-dien-22-oic acid
(1,4-BNC; Fig. 1, compound V) in molar ratios of 1 to 7% and
50 to 80%, respectively, depending on the substrate used (Ta-
ble 3). Thus, mutant strain RG32 is completely blocked in
steroid ring degradation and capable of selective sterol side
chain degradation, enabling analysis of putative sterol side
chain degradation genes.
Cloning homologous cholesterol catabolic genes from R.
rhodochrous DSM43269. Sequence data on the cholesterol cat-
abolic gene cluster of R. rhodochrous DSM43269, necessary to
perform mutational analysis of genes involved in sterol side
chain degradation in strain RG32, were not available yet.
Therefore, homologs of R. jostii RHA1 genes predicted to be
involved in sterol side chain degradation were cloned from
strain DSM43269. First, a genomic library of strain DSM43269
(22) was screened using degenerate PCR primers based on
amino acid sequences that were highly conserved among acti-
nobacterial homologs of strain RHA1 Ro04690 and FadE26
(Ro04693) (Fig. 2A). Library screening by PCR resulted in the
isolation of two separate clones that were sequenced and an-
alyzed (Fig. 2B and C). A 5.4-kb genomic fragment (Fig. 2B)
carried ro04690DSM43269, encoding a protein displaying 85%
TABLE 3. Whole-cell bioconversion of sterols/steroids into ADD
and 1,4-BNC by R. rhodochrous mutant strain RG32
after 72 h of incubation
a
Steroid substrate ADD
(molar %) 1,4-BNC (%)
4-Androstene-3,17-dione 69 (9) NA
23,24-Bisnorchol-5-en-22-oic acid-3-ol  60 (21)
Campesterol 1 (0) 49 (9)
5-Cholenic acid-3-ol 1 (0) 77 (4)
4-Cholestene-3-one 4 (1) 79 (2)
1,4-Cholestadiene-3-one 3 (1) 71 (4)
Cholesterol 3 (1) 73 (12)
-Sitosterol 7 (2) 67 (7)
a NA, not applicable; , not detected. The data represent the molar % con-
version as averages of triplicate experiments; standard deviations are shown in
parentheses.
4460 WILBRINK ET AL. APPL.E NVIRON.M ICROBIOL.amino acid sequence identity with Ro04690RHA1. Two genes
located immediately upstream of ro04690DSM43269 encode pro-
teins sharing 74% and 76% amino acid sequence identity with
the deduced amino acid sequences of echA19 (partial se-
quence) and fadD19 in strain RHA1, respectively. Three genes
located downstream of ro04690DSM43269 encode proteins show-
ing the highest similarities to Ro03510 (23%), Ro04422 (25%),
and Ro01580 (56%) of strain RHA1, respectively. Bioinfor-
matic analysis of the sequence of a 5.5-kb insert (Fig. 2C)
conﬁrmed the presence of fadE26DSM43269, whose gene prod-
uct displayed 86% amino acid sequence identity to its coun-
terpart in strain RHA1. Moreover, the fragment contained
genes that encode proteins with 46 to 70% amino acid se-
quence identities to fadD17 (partial sequence), fadE27, fdxD,
and hsd4A of strain RHA1, exhibiting identical genetic orga-
nizations (Fig. 2). The two cloned genomic fragments of strain
DSM43269 did not show sequence overlap.
FadD19 is essential for C-24 branched-chain sterol side
chain degradation. To substantiate a role of fadD17DSM43269,
fadD19DSM43269, fadE26DSM43269, fadE27DSM43269, and
ro04690DSM43269 in sterol side chain degradation, gene inacti-
vation mutants of strain RG32 were constructed. Biotransfor-
mations of cholesterol with whole-cell cultures of these mu-
tants revealed that all mutants displayed parental phenotypes,
with similar amounts of ADD and 1,4-BNC accumulating from
cholesterol as observed with parent strain RG32 (Table 4).
Although the putative CoA ligases encoded by fadD17 and
fadD19 show only a relatively low sequence identity at the
amino acid level (21 and 23% for strain RHA1 and strain
DSM43269, respectively), the possibility that they are func-
tional homologs able to cross-complement each other during
cholesterol catabolism could not be ruled out. Therefore, a
fadD17 inactivation mutant was constructed in strain
RG32fadD19 and its ability to degrade cholesterol was tested
by whole-cell biotransformation. Cholesterol degradation also
was unaffected in RG32fadD19 fadD17, displaying conver-
sion rates similar to that of strain RG32 (Table 4).
FadE26, FadE27, and Ro04690 all belong to the superfamily
of acyl-CoA dehydrogenases (7). We therefore also constructed a
double gene inactivated mutant strain, RG32ro04690DSM43269
fadE26, and a triple mutant, RG32ro04690DSM43269 fadE26
fadE27, to prevent possible cross-complementation. How-
ever, all these mutants were unaffected in cholesterol side
chain degradation and displayed parent strain RG32 pheno-
types (Table 4). Although clearly upregulated in strain RHA1
cells grown on cholesterol (Fig. 2A), either these R. rhodo-
chrous DSM42369 genes are not involved in cholesterol side
chain degradation or the reaction can be performed by addi-
tional isoenzymes encoded by strain DSM42369.
Next, all mutants were tested in whole-cell biotransforma-
tions with -sitosterol, a C-24–ethyl branched phytosterol (Fig.
1B). Interestingly, strain RG32fadD19 was blocked in its abil-
ity to convert the side chain of -sitosterol (Table 4). All other
mutants displayed parental strain phenotypes, accumulating
similar amounts of ADD and 1,4-BNC from -sitosterol as did
strain RG32 (Table 4). Further analysis of the RG32fadD19
mutant revealed that also the degradation of campesterol, a
C-24–methyl branched sterol, was blocked (Table 4).
When incubated with -sitosterol, strain RG32fadD19 ac-
cumulated metabolites that were not detected in strain RG32
(Fig. 3). These metabolites corresponded to ring-oxidized de-
rivatives of the -sitosterol mixture, i.e., 4-sitostene-3-one and
4-campestene-3-one, as was conﬁrmed by reference samples.
Mutant strain RG32fadD19 regained parental phenotype
when complemented with fadD19DSM43269 under the control of
the aphII promoter, with -sitosterol as the substrate (Table
4). This excluded the possibility that -sitosterol side chain
degradation in RG32fadD19 was blocked by polar effects
rather than by inactivation of fadD19 directly.
FadD19DSM43269 displays sterol-CoA ligase activity toward
C-26-oic acid steroids. The gene inactivation studies in strain
RG32 showed that fadD19 is essential for side chain degrada-
tion of branched-chain sterols. To substantiate that fadD19 en-
codes a steroid-CoA ligase, FadD19DSM43269 activity was tested.
Heterologous expression of the protein was achieved using
E. coli strain BL21(DE3) carrying pET15bfadD19DSM43269.
Cell extracts (CFE) derived from E. coli cultures expressing
FadD19DSM43269 were active toward 5-cholestene-26-oic acid-
3-ol, using ATP and CoA as cosubstrates (Fig. 4A). Since
CoA ligases require the presence of a carboxylic acid for their
activity, FadD19DSM43269 must have been active toward the
side chain of 5-cholestene-26-oic acid-3-ol. A negative con-
trol, consisting of the same components but with CFE obtained
from cultures of the same E. coli strain carrying empty pET15b
vector, did not show product formation (Fig. 4B). Incubations
of CFE containing FadD19DSM43269 also resulted in the for-
TABLE 4. Whole-cell bioconversion of sterols by R. rhodochrous RG32 and mutants thereof into ADD and
1,4-BNC, measured after 72 h of incubation
a
Strain
% conversion of sterol:
Cholesterol -Sitosterol Campesterol
ADD 1,4-BNC ADD 1,4-BNC ADD 1,4-BNC
RG32 3 (1) 73 (12) 7 (2) 67 (7) 1 (0) 49 (9)
RG32ro04690DSM43269 4( 1) 74 (8) 7 (4) 54 (9) ND ND
RG32ro04690DSM43269 fadE26 3( 1) 72 (4) 6 (4) 61 (9) ND ND
RG32ro04690DSM43269 fadE26 fadE27 3( 2) 70 (6) 7 (2) 65 (6) ND ND
RG32fadD17 3( 2) 74 (9) 8 (2) 64 (5) ND ND
RG32fadD19 6( 2) 64 (4) 
RG32fadD19pCOMPfadD19DSM43269 ND ND 6 (1) 60 (4) ND ND
RG32fadD19 fadD17 6( 2) 69 (1)  ND ND
a ND, not determined; , not detected. The data represent averages of duplicate experiments; standard deviations are shown in parentheses.
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acid or 5-cholenic acid-3-ol in a steroid substrate-, ATP-, and
CoA-dependent manner (Fig. 4A). Omitting any of these re-
action components resulted in loss of enzyme activity, indicat-
ing that these are all essential components. Therefore, the
products formed are most likely the CoA esters of 5-cho-
lestene-26-oic acid-3-ol and 3-oxo-4-cholestene-26-oic acid,
conﬁrming that FadD19DSM43269 functions as a steroid-CoA
FIG. 3. HPLC graphs of steroid extracts from -sitosterol bioconversions after 3 days of incubation. (A) Proﬁle of mutant strain RG32fadD19
showing the accumulation of metabolites (degradation pathway intermediates) that, based on identical HPLC retention times, were identiﬁed as
4-sitostene-3-one (I) and 4-campestene-3-one (II). (B) Proﬁle of parent strain RG32.
FIG. 4. (A) TLC analysis of the reactions of cell extracts (CFE) of E. coli BL21(DE3) cells expressing fadD19DSM43269, incubated with
5-cholestene-26-oic acid-3-ol (I), 3-oxo-4-cholestene-26-oic acid (II), and 5-cholenic acid-3-ol (III). (B) TLC analysis of reactions of CFE of
BL21 cells containing empty plasmid pET15b, using the same sterol substrates (I to III). All incubations were performed for4ha t30°C and
contained the cofactor Mg
2. ATP and CoA were either included () or omitted () as a negative control.
4462 WILBRINK ET AL. APPL.E NVIRON.M ICROBIOL.ligase. Activity toward C-24 branched-chain steroids with a
terminal carboxylic acid could not be tested, since these com-
pounds were not (commercially) available.
Bioinformatic analysis and phylogeny of R. jostii RHA1 CoA
ligases. Database searches served to identify homologs of both
FadD19RHA1 and FadD17RHA1 in closely related sterol-de-
grading actinobacteria, including Nocardia farcinica IFM
10152 (Nfa5290 and Nfa24170; with 75 and 47% identity, re-
spectively), Mycobacterium smegmatis strain MC2 155
(MSMEG_5914 and MSMEG_5908; with 67 and 57% identity,
respectively), M. tuberculosis H37Rv (Rv3515c and Rv3506;
with 67 and 56% identity, respectively), and Rhodococcus
equi 103S and ATCC 33707 (HMPREF0724_4865 and
HMPREF0724_4863; with 77 and 72% identity, respectively). A
comparison of FadD19RHA1 and FadD17RHA1 with the amino
acid sequence of the cholic acid-CoA ligase, encoded by baiB,
revealed relatively low similarities (24 and 20% identity, re-
spectively). All sequences in the strain RHA1 genome anno-
tated as CoA ligase or CoA synthetase were compared and
depicted in a phylogenetic tree (see Fig. S1 in the supple-
mental material). This revealed that the strain RHA1 ge-
nome contains closely related homologs of FadD17RHA1 and
FadD19RHA1, i.e., Ro05822 (44% identity) and Ro04675 (49%
identity), respectively. These putative enzymes thus may have a
similar steroid-CoA ligase activity, resulting in a metabolic
redundancy for activation of the side chain of 5-cholestene-26-
oic acid-3-ol metabolites.
DISCUSSION
This study identiﬁed FadD19 of R. rhodochrous DSM43269 as
a steroid-CoA ligase, essential for the degradation of C-24
branched-chain sterols in vivo. An unmarked fadD19 deletion
mutant in kshA null mutant strain RG32 was blocked in side chain
degradation of the C-24 branched sterols -sitosterol and
campesterol but not cholesterol (Table 4). In addition, mutant
RG32fadD19 accumulated ring-oxidized derivatives from
-sitosterol (Fig. 3), indicating that in this mutant no sterol side
chain degradation occurred, but only steroid ring oxidation. From
these results, we conclude that FadD19DSM43269 catalyzes an es-
sential step in the side chain degradation of C-24 branched sterols
in R. rhodochrous DSM43269.
In R. jostii RHA1, fadD17 is located proximal to fadD19
within the cholesterol catabolic gene cluster and highly upregu-
lated during growth on cholesterol. Thus, fadD17 is a likely
candidate to encode a steroid-CoA ligase involved in choles-
terol side chain activation (36). Mutant strains with an inacti-
vated fadD17DSM43269 gene in both RG32 and RG32fadD19,
however, were still capable of transformation of the cholesterol
side chain. Therefore, it remains elusive whether side chain
activation during cholesterol catabolism is performed by mul-
tiple redundant CoA ligases or whether a yet-unidentiﬁed,
highly speciﬁc enzyme catalyzes this reaction in vivo.
Direct enzyme activity measurements showed that
FadD19DSM43269 was able to activate the side chains of
various steroid carboxylic acids (Fig. 4). The intensities of the
reaction product spots suggest that FadD19DSM43269 has sub-
strate preference for steroids possessing longer side chains
over those with shorter ones. Furthermore, substrates with a
3-hydroxy-5-ene ring structure may be better substrates than
their oxidized forms. However, it is difﬁcult to quantitatively
compare the reaction products due to the discrepancy in spot
intensity between the 3-hydroxy-5-ene and 3-oxo-4-ene sub-
strates at the same substrate concentration. Additional bio-
chemical studies are thus required to assess the substrate spec-
iﬁcity of FadD19DSM43269.
Despite the fact that FadD19DSM43269 was able to activate
5-cholestene-26-oic acid-3-ol and derivatives thereof in vitro,
deletion of fadD19DSM43269 in strain RG32 did not affect cho-
lesterol degradation. Therefore, it is most plausible that, be-
sides fadD19 and possibly fadD17, other isoenzymes are en-
coded by the strain DSM43269 genome that can complement
5-cholestene-26-oic acid-3-ol activation in this mutant. Or-
thologs of Ro05822 and Ro04675 (see Fig. S1 in the supple-
mental material) may be present in strain DSM43269 and
could account for the lack of phenotype found with our mu-
tants in whole-cell biotransformations with cholesterol. CoA
ligases are known to be promiscuous enzymes, which often
have overlapping substrate speciﬁcities (3, 21), further sup-
porting the hypothesis that the genomes of strain RHA1 and
strain DSM43269 may encode multiple enzymes with the abil-
ity to activate the side chain of 5-cholestene-26-oic acid-3-ol
or derivatives thereof (e.g., its 3-oxo-4-ene metabolite).
Similarly, inactivation of multiple genes encoding putative acyl-
CoA dehydrogenases (i.e., fadE26DSM43269, fadE27DSM43269, and
ro04690DSM43269) in strain RG32 did not hamper cholesterol
nor -sitosterol side chain degradation (Table 4). Rhodococcal
genomes are very rich in genes encoding -oxidation enzymes,
making it very likely that enzymatic redundancy for these func-
tions exists. However, the possibility that the fadE26DSM43269,
fadE27DSM43269, and ro04690DSM43269 genes in fact do not have
a role in sterol side chain degradation cannot be ruled out at
the moment.
Interestingly, there is apparently no redundancy for activa-
tion of C-24 branched sterol side chains, since deletion of
fadD19DSM4269 alone in strain RG32 resulted in impaired deg-
radation of C-24 branched-chain sterols. FadD19DSM43269 may
be the only enzyme able to activate the side chains of C-24
branched phytosterols, which possess a bulkier side chain than
that of cholesterol. However, it cannot be excluded that a
homolog (e.g., Ro04675) is encoded by strain DSM43269 that
is able to catalyze the same reaction but that it is not expressed
in mutant RG32fadD19 under the conditions used.
The results described in our current study are consistent
with FadD19 of R. rhodochrous DSM43269 performing a ste-
roid-CoA ligase reaction with an in vivo role in the degradation
of C-24 branched sterol side chains. FadD19H37Rv of the hu-
man pathogen M. tuberculosis H37Rv, encoded by rv3515c,
possesses CoA ligase activity and catalyzes the formation of
acyl-CoA from long-chain fatty acids (31). BLAST searches
with FadD19DSM43269 and FadD19RHA1 against the H37Rv
genome showed that they both have the highest sequence iden-
tity with FadD19H37Rv; FadD19RHA1 and FadD19H37Rv also
were best reciprocal hits. The high similarity (67%) between
these enzymes suggests an in vivo role for FadD19H37Rv in
sterol metabolism of M. tuberculosis H37Rv.
The study furthermore described the construction of mutant
strain R. rhodochrous RG32, blocked in sterol ring degrada-
tion, and demonstrated its successful use as a tool to study the
process of microbial sterol side chain degradation speciﬁcally,
VOL. 77, 2011 FadD19 OF RHODOCOCCUS RHODOCHROUS DSM43269 4463allowing the future characterization of other putative sterol
side chain degradation genes.
ACKNOWLEDGMENTS
This work was ﬁnancially supported by grants of the IBOS (M.H.W.)
and B-Basic (M.P.) programs of ACTS (Advanced Chemical Technol-
ogies for Sustainability), NWO (Netherlands Organization for Scien-
tiﬁc Research).
REFERENCES
1. Arima, K., M. Nagasawa, M. Bae, and G. Tamura. 1969. Microbial trans-
formation of sterols. Part I. Decomposition of cholesterol by microorgan-
isms. Agric. Biol. Chem. 33:1636–1643.
2. Arima, K., T. Nakamatsu, and T. Beppu. 1978. Microbial production of
3-oxobisnorchola-1,4-dien-22-oic acid. Agric. Biol. Chem. 42:411–416.
3. Arora, P., A. Vats, P. Saxena, D. Mohanty, and R. S. Gokhale. 2005. Pro-
miscuous fatty acyl CoA ligases produce acyl-CoA and acyl-SNAC precur-
sors for polyketide biosynthesis. J. Am. Chem. Soc. 127:9388–9389.
4. Birkenmaier, A., et al. 2007. Biochemical and genetic investigation of initial
reactions in aerobic degradation of the bile acid cholate in Pseudomonas sp.
strain Chol1. J. Bacteriol. 189:7165–7173.
5. Capyk, J. K., et al. 2009. Mycobacterial cytochrome P450 125 (CYP125)
catalyzes the terminal hydroxylation of C27 steroids. J. Biol. Chem. 284:
35534–35542.
6. Chen, C. S. 1985. Ph.D. thesis. University of Wisconsin—Madison, Mad-
ison, WI.
7. Daubner, S. C., G. Gadda, M. P. Valley, and P. F. Fitzpatrick. 2002. Cloning
of nitroalkane oxidase from Fusarium oxysporum identiﬁes a new member of
the acyl-CoA dehydrogenase superfamily. Proc. Natl. Acad. Sci. U. S. A.
99:2702–2707.
8. Fernandes, P. J., J. A. Powell, and J. A. Archer. 2001. Construction of
Rhodococcus random mutagenesis libraries using Tn5 transposition com-
plexes. Microbiology 147:2529–2536.
9. Fujimoto, Y., C. S. Chen, Z. Szeleczky, D. Ditullio, and C. J. Sih. 1982.
Microbial degradation of the phytosterol side chain. I. Enzymic conversion
of 3-oxo-24-ethylcholest-4-en-26-oic acid into 3-oxochol-4-en-24-oic acid and
androst-4-ene-3,17-dione. J. Am. Chem. Soc. 104:4718–4720.
10. Fujimoto, Y., C. S. Chen, A. S. Gopalan, and C. J. Sih. 1982. Microbial
degradation of the phytosterol side chain. II. Incorporation of NaH
14CO3
onto the C-28 position. J. Am. Chem. Soc. 104:4720–4722.
11. Knol, J., K. Bodewits, G. I. Hessels, L. Dijkhuizen, and R. R. van der Geize.
2008. 3-Keto-5-steroid delta1-dehydrogenase from Rhodococcus erythropo-
lis SQ1 and its orthologue in Mycobacterium tuberculosis H37Rv are highly
speciﬁc enzymes that function in cholesterol catabolism. Biochem. J. 410:
339–346.
12. Mallonee, D. H., J. L. Adams, and P. B. Hylemon. 1992. The bile acid-
inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile
acid-coenzyme A ligase. J. Bacteriol. 174:2065–2071.
13. Marsheck, W. J., S. Kraychy, and R. D. Muir. 1972. Microbial degradation
of sterols. Appl. Microbiol. 23:72–77.
14. Martin, C. K. A., and F. Wagner. 1976. Microbial transformation of -sito-
sterol by Nocardia sp. M29. Eur. J. Appl. Microbiol. 2:243–255.
15. McLean, K. J., et al. 2009. The structure of Mycobacterium tuberculosis
CYP125: molecular basis for cholesterol binding in a P450 needed for host
infection. J. Biol. Chem. 284:35524–35533.
16. McLeod, M. P., et al. 2006. The complete genome of Rhodococcus sp. RHA1
provides insights into a catabolic powerhouse. Proc. Natl. Acad. Sci. U. S. A.
103:15582–15587.
17. Mohn, W. W., et al. 2008. The actinobacterial mce4 locus encodes a steroid
transporter. J. Biol. Chem. 283:35368–35374.
18. Nesbitt, N. M., et al. 2010. A thiolase of Mycobacterium tuberculosis is
required for virulence and production of androstenedione and androsta-
dienedione from cholesterol. Infect. Immun. 78:275–282.
19. Ouellet, H., et al. 2010. Mycobacterium tuberculosis CYP125A1, a steroid C27
monooxygenase that detoxiﬁes intracellularly generated cholest-4-en-3-one.
Mol. Microbiol. 77:730–742.
20. Pandey, A. K., and C. M. Sassetti. 2008. Mycobacterial persistence requires
the utilization of host cholesterol. Proc. Natl. Acad. Sci. U. S. A. 105:4376–
4380.
21. Pei, Z., et al. 2003. The acyl-CoA synthetase “bubblegum” (lipidosin): fur-
ther characterization and role in neuronal fatty acid beta-oxidation. J. Biol.
Chem. 278:47070–47078.
22. Petrusma, M., L. Dijkhuizen, and R. van der Geize. 2009. Rhodococcus
rhodochrous DSM 43269 3-ketosteroid 9-hydroxylase, a two-component
iron-sulfur-containing monooxygenase with subtle steroid substrate speciﬁc-
ity. Appl. Environ. Microbiol. 75:5300–5307.
23. Rosłoniec, K. Z., et al. 2009. Cytochrome P450 125 (CYP125) catalyzes
C26-hydroxylation to initiate sterol side chain degradation in Rhodococcus
jostii RHA1. Mol. Microbiol. 74:1031–1043.
24. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a
laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY.
25. Scha ¨fer, A., A. Tauch, W. Ja ¨ger, J. Kalinowski, G. Thierbach, and A. Pu ¨hler.
1994. Small mobilizable multi-purpose cloning vectors derived from the
Escherichia coli plasmids pK18 and pK19: selection of deﬁned deletions in
the chromosome of Corynebacterium glutamicum. Gene 145:69–73.
26. Sih, C. J. 1962. Mechanisms of steroid oxidation by microorganisms.
Biochim. Biophys. Acta 62:541–547.
27. Sih, C. J., H. H. Tai, Y. Y. Tsong, S. S. Lee, and R. G. Coombe. 1968.
Mechanisms of steroid oxidation by microorganisms. XIV. Pathway of cho-
lesterol side-chain degradation. Biochemistry 7:808–818.
28. Sih, C. J., K. C. Wang, and H. H. Tai. 1968. Mechanism of steroid oxidation
by microorganisms. XIII. C22 acid intermediates in the degradation of the
cholesterol side chain. Biochemistry 7:796–807.
29. Szentirmai, A. 1990. Microbial physiology of sidechain degradation of ste-
rols. J. Ind. Microbiol. 6:101–116.
30. Tamura, K., J. Dudley, M. Nei, and S. Kumar. 2007. MEGA4: Molecular
Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol.
Evol. 24:1596–1599.
31. Trivedi, O. A., et al. 2004. Enzymic activation and transfer of fatty acids as
acyl-adenylates in mycobacteria. Nature 428:441–445.
32. van der Geize, R., et al. 2008. A novel method to generate unmarked gene
deletions in the intracellular pathogen Rhodococcus equi using 5-ﬂuorocy-
tosine conditional lethality. Nucleic Acids Res. 36:e151.
33. van der Geize, R., G. I. Hessels, M. Nienhuis-Kuiper, and L. Dijkhuizen.
2008. Characterization of a second Rhodococcus erythropolis SQ1 3-keto-
steroid 9-hydroxylase activity comprising a terminal oxygenase homologue,
KshA2, active with oxygenase-reductase component KshB. Appl. Environ.
Microbiol. 74:7197–7203.
34. van der Geize, R., G. I. Hessels, R. van Gerwen, P. van der Meijden, and L.
Dijkhuizen. 2001. Unmarked gene deletion mutagenesis of kstD, encoding
3-ketosteroid 1-dehydrogenase, in Rhodococcus erythropolis SQ1 using
sacB as counter-selectable marker. FEMS Microbiol. Lett. 205:197–202.
35. van der Geize, R., G. I. Hessels, R. Van Gerwen, P. Van der Meijden, and L.
Dijkhuizen. 2002. Molecular and functional characterization of kshA and
kshB, encoding two components of 3-ketosteroid 9-hydroxylase, a class IA
monooxygenase, in Rhodococcus erythropolis strain SQ1. Mol. Microbiol.
45:1007–1018.
36. van der Geize, R., et al. 2007. A gene cluster encoding cholesterol catabolism
in a soil actinomycete provides insight into Mycobacterium tuberculosis sur-
vival in macrophages. Proc. Natl. Acad. Sci. U. S. A. 104:1947–1952.
37. Watanabe, K., H. Aihara, N. Tachi, and R. Nakamura. 1987. Degradations
of 4-cholesten-3-one and 1,4-androstadiene-3,17-dione by cholesterol-de-
grading bacteria. J. Appl. Bacteriol. 62:151–155.
4464 WILBRINK ET AL. APPL.E NVIRON.M ICROBIOL.